首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1379896篇
  免费   82702篇
  国内免费   2087篇
耳鼻咽喉   19650篇
儿科学   45649篇
妇产科学   36772篇
基础医学   195643篇
口腔科学   38466篇
临床医学   118728篇
内科学   258242篇
皮肤病学   32251篇
神经病学   105224篇
特种医学   58828篇
外国民族医学   310篇
外科学   210617篇
综合类   23673篇
现状与发展   1篇
一般理论   309篇
预防医学   96239篇
眼科学   31775篇
药学   107812篇
  9篇
中国医学   3259篇
肿瘤学   81228篇
  2018年   17264篇
  2017年   14677篇
  2016年   15923篇
  2015年   18609篇
  2014年   22397篇
  2013年   30120篇
  2012年   46485篇
  2011年   43934篇
  2010年   25209篇
  2009年   24581篇
  2008年   39081篇
  2007年   42587篇
  2006年   43275篇
  2005年   49328篇
  2004年   48894篇
  2003年   43634篇
  2002年   38052篇
  2001年   67632篇
  2000年   67235篇
  1999年   58937篇
  1998年   14123篇
  1997年   12282篇
  1996年   12110篇
  1995年   11273篇
  1994年   10240篇
  1993年   9638篇
  1992年   44582篇
  1991年   43199篇
  1990年   42852篇
  1989年   41129篇
  1988年   37120篇
  1987年   36061篇
  1986年   33991篇
  1985年   31701篇
  1984年   22898篇
  1983年   19137篇
  1982年   10133篇
  1979年   21005篇
  1978年   13994篇
  1977年   12262篇
  1976年   10659篇
  1975年   12781篇
  1974年   14988篇
  1973年   14262篇
  1972年   13778篇
  1971年   13113篇
  1970年   12079篇
  1969年   11641篇
  1968年   10430篇
  1967年   9490篇
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
Quality of Life Research - The COVID-19 pandemic might add to the stressors experienced by people living with rheumatic diseases. This study aimed to examine rheumatic patients’ functional...  相似文献   
3.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
4.
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered.  相似文献   
5.
6.
7.
8.
9.
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号